Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,083 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of previous drug-eluting stent restenosis in non-left main coronary artery lesions on long-term outcomes after left main coronary artery stenting: an observation from the AOI-LMCA registry.
Higami H, Toyofuku M, Morimoto T, Ohya M, Fuku Y, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kadota K, Kimura T; AOI LMCA Stenting Registry Investigators. Higami H, et al. Among authors: kadota k. Cardiovasc Interv Ther. 2018 Oct;33(4):350-359. doi: 10.1007/s12928-017-0497-2. Epub 2017 Oct 19. Cardiovasc Interv Ther. 2018. PMID: 29052105 Clinical Trial.
The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis.
Habara S, Mitsudo K, Goto T, Kadota K, Fujii S, Yamamoto H, Kato H, Takenaka S, Fuku Y, Hosogi S, Hirono A, Yamamoto K, Tanaka H, Hasegawa D, Nakamura Y, Tasaka H, Otsuru S, Okamoto Y, Yamada C, Miyamoto M, Inoue K. Habara S, et al. Among authors: kadota k. Heart. 2008 Sep;94(9):1162-5. doi: 10.1136/hrt.2007.128595. Epub 2007 Nov 21. Heart. 2008. PMID: 18032460
Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K; j-Cypher Registry Investigators. Kimura T, et al. Among authors: kadota k. Circulation. 2009 Feb 24;119(7):987-95. doi: 10.1161/CIRCULATIONAHA.108.808311. Epub 2009 Feb 9. Circulation. 2009. PMID: 19204304
Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry).
Nakagawa Y, Kimura T, Morimoto T, Nomura M, Saku K, Haruta S, Muramatsu T, Nobuyoshi M, Kadota K, Fujita H, Tatami R, Shiode N, Nishikawa H, Shibata Y, Miyazaki S, Murata Y, Honda T, Kawasaki T, Doi O, Hiasa Y, Hayashi Y, Matsuzaki M, Mitsudo K; j-Cypher Registry Investigators. Nakagawa Y, et al. Among authors: kadota k. Am J Cardiol. 2010 Aug 1;106(3):329-36. doi: 10.1016/j.amjcard.2010.03.031. Epub 2010 Jun 18. Am J Cardiol. 2010. PMID: 20643241
Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis.
Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y, Eguchi H, Miyake K, Yoshino M. Habara S, et al. Among authors: kadota k. JACC Cardiovasc Interv. 2011 Feb;4(2):149-54. doi: 10.1016/j.jcin.2010.10.012. JACC Cardiovasc Interv. 2011. PMID: 21349452 Free article. Clinical Trial.
Serial clinical and angiographic follow-up after phosphorylcholine-coated stent implantation.
Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y. Habara S, et al. Among authors: kadota k. Int Heart J. 2011;52(2):88-91. doi: 10.1536/ihj.52.88. Int Heart J. 2011. PMID: 21483166 Free article.
Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation.
Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, Fuku Y, Hosogi S, Hirono A, Tanaka H, Tada T, Morimoto T, Shiomi H, Kozuma K, Inoue K, Suzuki N, Kimura T, Mitsudo K. Imai M, et al. Among authors: kadota k. Circulation. 2011 May 31;123(21):2382-91. doi: 10.1161/CIRCULATIONAHA.110.003459. Epub 2011 May 16. Circulation. 2011. PMID: 21576652
Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach.
Tamura T, Kimura T, Morimoto T, Nakagawa Y, Furukawa Y, Kadota K, Tatami R, Kawai K, Sone T, Miyazaki S, Mitsudo K; j-Cypher Registry Investigators. Tamura T, et al. Among authors: kadota k. EuroIntervention. 2011 Sep;7(5):588-96. doi: 10.4244/EIJV7I5A95. EuroIntervention. 2011. PMID: 21930463 Free article.
1,083 results